Literature DB >> 31296337

A multicentre assessment of prostate MRI quality and compliance with UK and international standards.

P R Burn1, S J Freeman2, A Andreou3, N Burns-Cox4, R Persad5, T Barrett6.   

Abstract

AIM: To assess prostate magnetic resonance imaging (MRI) image quality and compliance with technical standards between centres in the South West region of the UK.
MATERIALS AND METHODS: Fifteen imaging sites in the region submitted seven consecutive anonymised MRI studies. These were assessed by two experienced radiologists in consensus. Overall, subjective image quality for T2-weighted imaging (T2W), diffusion weighted imaging (DWI), and dynamic contrast enhancement (DCE) was scored on a five-point Likert scale. Five additional quality parameters were also assessed visually, including image noise, motion, artefact, and distortion. The degree of compliance by each site with 21 published technical standards was also assessed.
RESULTS: Ninety-four MRI examinations were reviewed from across all sites (mean 6.3 scans per site, range 5-7). Mean compliance with technical standards was 63% (range 38-86%). Forty-seven percent of sites did not perform DCE. One site used a 3 T scanner. The percentage of patients with overall quality scores of ≥3 (diagnostically acceptable) were 68% for T2W, 81% for DWI, and 60% for both T2W and DWI. Ninety-three percent of the 45 patients who underwent DCE had diagnostically acceptable studies. By scanner age, the percentage of patients with diagnostically acceptable T2W scores was 53% for scanners ≥7 years and 80% when <7 years (p=0.006). Comparing individual sites, the mean overall quality scores were 2.9 (range 2.2-4.2) for T2W, 3.2 (1.8-4.7) for DWI, and 3.4 (2.5-4.7) for DCE.
CONCLUSION: There is wide variation in compliance with recognised technical standards and image quality across sites. If MRI is to replace biopsy in selected low-risk patients, improvements in image quality may be required.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31296337     DOI: 10.1016/j.crad.2019.03.026

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.

Authors:  Francesco Giganti; Alexander P Cole; Fiona M Fennessy; Timothy Clinton; Pedro Lopes Da Frota Moreira; Mariana Costa Bernardes; Carl-Fredrik Westin; Deepa Krishnaswamy; Andriy Fedorov; Daniel A Wollin; Bjoern Langbein; Nicola Frego; Muhieddine Labban; Joy S Badaoui; Steven L Chang; Logan G Briggs; Junichi Tokuda; Alessandro Ambrosi; Alex Kirkham; Mark Emberton; Veeru Kasivisvanathan; Caroline M Moore; Clare Allen; Clare M Tempany
Journal:  Eur Radiol       Date:  2022-06-30       Impact factor: 7.034

2.  The effect of capped biparametric magnetic resonance imaging slots on weekly prostate cancer imaging workload.

Authors:  Nikita Sushentsev; Iztok Caglic; Evis Sala; Nadeem Shaida; Rhys A Slough; Bruno Carmo; Vasily Kozlov; Vincent J Gnanapragasam; Tristan Barrett
Journal:  Br J Radiol       Date:  2020-02-03       Impact factor: 3.039

Review 3.  Imaging quality and prostate MR: it is time to improve.

Authors:  Francesco Giganti; Clare Allen
Journal:  Br J Radiol       Date:  2020-11-11       Impact factor: 3.039

4.  Practice Patterns and Challenges of Performing and Interpreting Prostate MRI: A Survey by the Society of Abdominal Radiology Prostate Disease-Focused Panel.

Authors:  Silvia D Chang; Daniel J A Margolis; Baris Turkbey; Abigail A Arnold; Sadhna Verma
Journal:  AJR Am J Roentgenol       Date:  2021-02-10       Impact factor: 6.582

5.  ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.

Authors:  Maarten de Rooij; Bas Israël; Marcia Tummers; Hashim U Ahmed; Tristan Barrett; Francesco Giganti; Bernd Hamm; Vibeke Løgager; Anwar Padhani; Valeria Panebianco; Philippe Puech; Jonathan Richenberg; Olivier Rouvière; Georg Salomon; Ivo Schoots; Jeroen Veltman; Geert Villeirs; Jochen Walz; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2020-05-19       Impact factor: 5.315

6.  Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.

Authors:  Nikita Sushentsev; Joshua D Kaggie; Rhys A Slough; Bruno Carmo; Tristan Barrett
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

7.  PI-QUAL v.1: the first step towards good-quality prostate MRI.

Authors:  Maarten de Rooij; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2021-11-29       Impact factor: 7.034

Review 8.  Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.

Authors:  Francesco Giganti; Veeru Kasivisvanathan; Alex Kirkham; Shonit Punwani; Mark Emberton; Caroline M Moore; Clare Allen
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

Review 9.  Optimal biopsy approach for detection of clinically significant prostate cancer.

Authors:  Simona Ippoliti; Peter Fletcher; Luca Orecchia; Roberto Miano; Christof Kastner; Tristan Barrett
Journal:  Br J Radiol       Date:  2021-08-06       Impact factor: 3.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.